Biotech Values

[fid]

> MCU – Why doesn't mc-1 seem like an undervalued asset, in your opinion?<


MC-1 failed to meet its primary endpts in the initial Phase II/III trial. Most importantly there was no mortality benefit.

Check my post #26946.

fid